FDA DEVICE FACTS
Primelase Excellence
High Technology Products S.L.U
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Intended Use:
PRIMELASE Excellence is intended for use in dermatologic and general surgical procedures.
Indications for Use:
PRIMELASE Excellence System with 810nm Laser applicator is intended for:
* Hair Removal with Static and Dynamic modes intended for permanent reduction in hair regrowth, defined as a long term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime.
* Treatment of Pseudofolliculitis barbae (PFB).
* Use on all skin types (Fitzpatrick I-VI).
* Treatment of benign pigmented lesions
PRIMELASE Excellence System with 755nm Laser applicator is intended for:
* Hair Removal with Static and Dynamic modes intended for permanent reduction in hair regrowth, defined as a long term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime.
* Treatment of Pseudofolliculitis barbae (PFB).
* Use on all skin types (Fitzpatrick I-VI).
+ Treatment of benign pigmented lesions
PRIMELASE Excellence System with 1060nm Laser applicator is intended for:
* Hair Removal with Static and Dynamic modes intended for permanent reduction in hair regrowth, defined as a long term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime.
* Treatment of Pseudofolliculitis barbae (PFB).
* Use on all skin types (Fitzpatrick I-VI).
* Treatment of benign vascular lesions, including angiomas, hemangiomas, telangiectasia, and other benign vascular lesions and leg veins.
+ Treatment of wrinkles
PRIMELASE Excellence System with 810-1060nm Laser applicator is intended for:
* Hair Removal with Static and Dynamic modes intended for permanent reduction in hair regrowth, defined as a long term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime.
* Treatment of Pseudofolliculitis barbae (PFB).
* Use on all skin types (Fitzpatrick I-VI).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。